← Back to VPO News
📊 Blog

DFree Secures ~¥100 Million to Scale Production and Support Amid Favorable Policy Changes

#DFree株式会社 #Funding #国内スタートアップ
VENTURE PITCH ONLINE
2026/07/31
Cover
📄 Table of Contents

Funding Overview

DFree Inc. has launched a new share acquisition rights-based funding round via FUNDINNO, an equity-based crowdfunding platform operated by FUNDINNO Corporation. The subscription period is scheduled from July 29, 2026, to August 6, 2026. This capital injection is intended to bolster the production of the company's flagship excretion prediction device, "DFree," while expanding implementation and support systems for nursing care facilities and child potty training programs. This move is part of a broader strategy to meet surging product demand and strengthen organizational structure with an eye toward a future IPO.

About DFree Inc.

DFree Inc. is a healthcare startup dedicated to leveraging technology to address challenges related to excretion. Their core product, "DFree," combines ultrasonic sensing technology with proprietary AI algorithms to monitor bladder fullness in real-time, accurately predicting the optimal time for excretion. Beyond reducing the burden on medical and nursing staff, the device is increasingly being adopted for child toilet training and various other applications. The company has received recognition from prominent bodies, including NEDO, AMED, and the Ministry of Economy, Trade and Industry’s "J-Startup" program.

Purpose of Funding and Future Outlook

The funds raised will be primarily allocated toward:

The recent establishment of a "urination independence support supplement" in the April 2026 revision of medical service fees has acted as a significant tailwind, resulting in a surge of inquiries from care facilities. Looking ahead, DFree aims to expand beyond excretion to predict biological changes related to nutrition, sleep, disease, and aging, ultimately striving to realize a society where everyone can maximize their quality of life.

Share This